Nasdaq · CIK 0001019034
BKYI BIO KEY INTERNATIONAL INC
Insider trading from SEC Form 4. Last filing Jul 2, 2026. Close $1.67 on Oct 9, 2026, 0% from the 52-week low and -84% from the high.
In brief
BIO KEY INTERNATIONAL INC (BKYI) has 41 SEC Form 4 filings on file from 8 insiders, the latest filed on Jul 2, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
11 open-market trades have been scored at BKYI. The newest: Michael W Depasquale (Chief Executive Officer) bought $3,233 of stock on Sep 15, 2025, filed Sep 17, 2025, scored 33 (weak). The largest of the 11 shown: James David Sullivan (Chief Legal Officer) bought $50k on Oct 30, 2023, scored 58 (moderate). 2 insiders bought within 14 days of each other around Nov 30, 2023.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at BIO KEY INTERNATIONAL INC, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | Michael W Depasquale Chief Executive Officer buy | $3,233 4,117 shares | +4% | +36% from low-66% from high | |
| 33Weak | Michael W Depasquale Chief Executive Officer buy | $3,233 4,117 shares | +4% | +36% from low-66% from high | |
| 29Weak | James David Sullivan Chief Legal Officer buy | $7,700 10,000 shares | +22% | +31% from low-68% from high | |
| 33Weak | Michael W Depasquale Chief Executive Officer buy | $3,900 5,000 shares | +10% | - | |
| 28Weak | Michael W Depasquale Chief Executive Officer buy | $3,320 4,000 shares | +9% | - | |
| 28Weak | Michael W Depasquale Chief Executive Officer buy | $4,050 5,000 shares | +13% | - | |
| 39Weak | James David Sullivan Chief Legal Officer buy | $3,300 20,000 shares | +5% | +47% from low-78% from high | |
| 44Moderate | Michael W Depasquale Chief Executive Officer buy | $3,600 20,000 shares | +7% | +27% from low-81% from high | |
| 39Weak | James David Sullivan Chief Legal Officer buy | $6,505 39,671 shares | +12% | +13% from low-84% from high | |
| 61Notable | Michael W Depasquale Chief Executive Officer buy | $29k 165,000 shares | +135% | 0% from low-90% from high | |
| 58Moderate | James David Sullivan Chief Legal Officer buy | $50k 285,100 shares | +218% | 0% from low-90% from high |
Transactions
The newest 50 of 55 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | James David Sullivan Chief Legal Officer | AGrant or award Common Stock | +250 | $3.83 | $958 | 9,986 | Jul 2, 2026 |
| Jun 30, 2026 | Michael W Depasquale Chief Executive Officer | AGrant or award Common Stock | +250 | $3.83 | $958 | 10,778 | Jul 2, 2026 |
| Jun 30, 2026 | Mira K Lacous Chief Technology Officer | AGrant or award Common Stock | +250 | $3.83 | $958 | 4,076 | Jul 2, 2026 |
| Dec 31, 2025 | Mira K Lacous Chief Technology Officer | AGrant or award Common Stock | +2,500 | $0.46 | $1,150 | 38,258 | Jan 5, 2026 |
| Dec 31, 2025 | James David Sullivan Chief Legal Officer | AGrant or award Common Stock | +2,500 | $0.46 | $1,150 | 97,351 | Jan 5, 2026 |
| Dec 31, 2025 | Michael W Depasquale Chief Executive Officer | AGrant or award Common Stock | +2,500 | $0.46 | $1,150 | 105,275 | Jan 5, 2026 |
| Sep 15, 2025 | Michael W Depasquale Chief Executive Officer | POpen-market purchase Common Stock | +2,500 | $0.75 | $1,875 | 101,158 | Sep 17, 2025 |
| Sep 15, 2025 | Michael W Depasquale Chief Executive Officer | POpen-market purchase Common Stock | +2,500 | $0.75 | $1,875 | 110,557 | Sep 17, 2025 |
| Sep 16, 2025 | Michael W Depasquale Chief Executive Officer | POpen-market purchase Common Stock | +1,617 | $0.84 | $1,358 | 102,775 | Sep 17, 2025 |
| Sep 16, 2025 | Michael W Depasquale Chief Executive Officer | POpen-market purchase Common Stock | +1,617 | $0.84 | $1,358 | 112,174 | Sep 17, 2025 |
| Sep 2, 2025 | Mira K Lacous Chief Technology Officer | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 35,758 | Sep 3, 2025 |
| Sep 2, 2025 | Michael W Depasquale Chief Executive Officer | AGrant or award Common Stock | +45,000 | $0.00 | $0 | 98,658 | Sep 3, 2025 |
| Sep 2, 2025 | James David Sullivan Chief Legal Officer | AGrant or award Common Stock | +40,000 | $0.00 | $0 | 94,851 | Sep 3, 2025 |
| Sep 2, 2025 | Cecilia C Welch Chief Financial Officer | AGrant or award Common Stock | +35,000 | $0.00 | $0 | 59,396 | Sep 3, 2025 |
| Aug 22, 2025 | James David Sullivan Chief Legal Officer | POpen-market purchase Common Stock | +10,000 | $0.77 | $7,700 | 54,851 | Aug 26, 2025 |
| Jun 30, 2025 | Mira K Lacous Chief Technology Officer | AGrant or award Common Stock | +139 | $0.70 | $97 | 10,758 | Jul 2, 2025 |
| Jun 30, 2025 | James David Sullivan Chief Legal Officer | AGrant or award Common Stock | +139 | $0.70 | $97 | 44,851 | Jul 2, 2025 |
| Jun 30, 2025 | Michael W Depasquale Chief Executive Officer | AGrant or award Common Stock | +139 | $0.70 | $97 | 53,658 | Jul 2, 2025 |
| Jun 13, 2025 | Michael W Depasquale Chief Executive Officer | POpen-market purchase Common Stock | +5,000 | $0.78 | $3,900 | 53,519 | Jun 16, 2025 |
| Jun 3, 2025 | Michael W Depasquale Chief Executive Officer | POpen-market purchase Common Stock | +4,000 | $0.83 | $3,320 | 48,519 | Jun 4, 2025 |
| Jun 3, 2025 | Michael W Depasquale Chief Executive Officer | POpen-market purchase Common Stock | +5,000 | $0.81 | $4,050 | 44,519 | Jun 3, 2025 |
| May 27, 2025 | Emmanuel Alia director | AGrant or award Common Stock | +5,000 | $0.00 | $0 | 21,323 | May 27, 2025 |
| May 27, 2025 | Cameron E. Williams director | AGrant or award Common Stock | +5,000 | $0.00 | $0 | 20,684 | May 27, 2025 |
| May 27, 2025 | Robert J Michel director | AGrant or award Common Stock | +5,000 | $0.00 | $0 | 22,303 | May 27, 2025 |
| May 27, 2025 | Fong Wong Kwok Managing Director, BIO-key HK | AGrant or award Common Stock | +2,000 | $0.00 | $0 | 35,248 | May 27, 2025 |
| May 27, 2025 | Cameron E. Williams director | AGrant or award Common Stock | +1,266 | $0.00 | $0 | 21,950 | May 27, 2025 |
| May 27, 2025 | Robert J Michel director | AGrant or award Common Stock | +1,266 | $0.79 | $1,000 | 23,569 | May 27, 2025 |
| May 8, 2025 | Emmanuel Alia director | AGrant or award Common Stock | +3,897 | $0.00 | $0 | 16,323 | May 12, 2025 |
| May 8, 2025 | Robert J Michel director | AGrant or award Common Stock | +3,897 | $0.00 | $0 | 17,303 | May 12, 2025 |
| May 8, 2025 | Cameron E. Williams director | AGrant or award Common Stock | +3,897 | $0.00 | $0 | 15,684 | May 12, 2025 |
| Mar 20, 2025 | Robert J Michel director | AGrant or award Common Stock | +2,971 | $0.00 | $0 | 13,406 | Mar 21, 2025 |
| Mar 20, 2025 | Cameron E. Williams director | AGrant or award Common Stock | +2,971 | $0.00 | $0 | 11,787 | Mar 21, 2025 |
| Mar 20, 2025 | Emmanuel Alia director | AGrant or award Common Stock | +2,971 | $0.00 | $0 | 12,426 | Mar 21, 2025 |
| Dec 31, 2024 | James David Sullivan Chief Legal Officer | AGrant or award Common Stock | +139 | $1.40 | $195 | 44,712 | Jan 3, 2025 |
| Dec 31, 2024 | Michael W Depasquale Chief Executive Officer | AGrant or award Common Stock | +139 | $1.40 | $195 | 39,519 | Jan 3, 2025 |
| Dec 31, 2024 | Mira K Lacous Chief Technology Officer | AGrant or award Common Stock | +139 | $1.40 | $195 | 10,619 | Jan 3, 2025 |
| Nov 7, 2024 | Emmanuel Alia director | AGrant or award Common Stock | +2,587 | $0.00 | $0 | 9,455 | Nov 8, 2024 |
| Nov 7, 2024 | Cameron E. Williams director | AGrant or award Common Stock | +2,587 | $0.00 | $0 | 8,816 | Nov 8, 2024 |
| Nov 7, 2024 | Robert J Michel director | AGrant or award Common Stock | +2,587 | $0.00 | $0 | 10,435 | Nov 8, 2024 |
| Mar 27, 2024 | Emmanuel Alia director | AGrant or award Common Stock | +1,429 | $0.00 | $0 | 3,368 | Mar 29, 2024 |
| Dec 1, 2023 | Michael W Depasquale Chief Executive Officer | POpen-market purchase Common Stock | +20,000 | $0.18 | $3,600 | 306,827 | Dec 4, 2023 |
| Nov 30, 2023 | James David Sullivan Chief Legal Officer | POpen-market purchase Common Stock | +20,000 | $0.17 | $3,300 | 388,171 | Dec 4, 2023 |
| Nov 24, 2023 | James David Sullivan Chief Legal Officer | POpen-market purchase Common Stock | +10,000 | $0.16 | $1,600 | 338,500 | Nov 28, 2023 |
| Nov 24, 2023 | James David Sullivan Chief Legal Officer | POpen-market purchase Common Stock | +17,609 | $0.17 | $2,905 | 356,109 | Nov 28, 2023 |
| Nov 24, 2023 | James David Sullivan Chief Legal Officer | POpen-market purchase Common Stock | +959 | $0.17 | $166 | 357,068 | Nov 28, 2023 |
| Nov 24, 2023 | James David Sullivan Chief Legal Officer | POpen-market purchase Common Stock | +1,100 | $0.17 | $190 | 358,168 | Nov 28, 2023 |
| Nov 27, 2023 | James David Sullivan Chief Legal Officer | POpen-market purchase Common Stock | +9,803 | $0.16 | $1,608 | 367,971 | Nov 28, 2023 |
| Nov 27, 2023 | James David Sullivan Chief Legal Officer | POpen-market purchase Common Stock | +100 | $0.18 | $18 | 368,071 | Nov 28, 2023 |
| Nov 27, 2023 | James David Sullivan Chief Legal Officer | POpen-market purchase Common Stock | +100 | $0.18 | $18 | 368,171 | Nov 28, 2023 |
| Oct 30, 2023 | Michael W Depasquale Chief Executive Officer | POpen-market purchase Common Stock | +165,000 | $0.18 | $29k | 286,827 | Nov 1, 2023 |
Insiders
Everyone who has filed a Form 4 here.
- Emmanuel Aliadirector
- Michael W DepasqualeChief Executive Officer
- Fong Wong KwokManaging Director, BIO-key HK
- Mira K LacousChief Technology Officer
- Robert J Micheldirector, cfo, officer
- James David SullivanChief Legal Officer
- Cecilia C WelchChief Financial Officer
- Cameron E. Williamsdirector
Questions about BKYI
Answered from the filings on this page, as of the latest one.
Are insiders buying BKYI?
No. In the last 90 days no insider at BIO KEY INTERNATIONAL INC bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade BKYI on the open market?
Michael W Depasquale (Chief Executive Officer) bought $3,233 of BKYI on Sep 15, 2025 and filed the Form 4 on Sep 17, 2025. InsiderTell scored 33 (weak).
How many insiders file Form 4 at BIO KEY INTERNATIONAL INC?
8 people have filed a Form 4 at BIO KEY INTERNATIONAL INC, among them Emmanuel Alia (director), Michael W Depasquale (Chief Executive Officer), Fong Wong Kwok (Managing Director, BIO-key HK). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.